---
title: "VC: Q2 2026 delivered 4% growth over market, robust launches, and strong cash returns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293607446.md"
description: "Q2 2026 saw $960M in sales and 4% growth over market, driven by 24 new launches and $2B in new business wins. Adjusted EBITDA margin was 12.1%, with strong cash generation and a $200M share repurchase initiated. Full-year guidance trends toward the high end for sales andriginal document: Visteon Corporation [VC] Slides Release — Jul. 23 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-23T11:26:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293607446.md)
  - [en](https://longbridge.com/en/news/293607446.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293607446.md)
generator: "portal-rs"
---

# VC: Q2 2026 delivered 4% growth over market, robust launches, and strong cash returns

Q2 2026 saw $960M in sales and 4% growth over market, driven by 24 new launches and $2B in new business wins. Adjusted EBITDA margin was 12.1%, with strong cash generation and a $200M share repurchase initiated. Full-year guidance trends toward the high end for sales and EBITDA.

Original document: Visteon Corporation \[VC\] Slides Release — Jul. 23 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [VC.US](https://longbridge.com/en/quote/VC.US.md)

## Related News & Research

- [Visteon Q2 sales slightly beat on new product launch ramps](https://longbridge.com/en/news/293603794.md)
- [VC: Q2 2026 net income fell to $49M on $960M sales; new $800M buyback and $24M acquisition announced](https://longbridge.com/en/news/293607122.md)
- [Iomart publishes 2026 annual report](https://longbridge.com/en/news/297739507.md)
- [ALMS: Envudeucitinib showed strong efficacy in IFNGS-high SLE patients and was well tolerated](https://longbridge.com/en/news/297666957.md)
- [Cognizant declares dividend of R$ 1.15 per unit for 3Q 2026 BDRs](https://longbridge.com/en/news/297326890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**